HER2-targeted therapies: how far we've come--and where we're headed

Oncology (Williston Park). 2011 Apr 30;25(5):425-6.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • Female
  • Genes, erbB-2*
  • Humans
  • Lapatinib
  • Quinazolines / therapeutic use*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Quinazolines
  • Lapatinib
  • Trastuzumab